Voices
The Science Behind TIL Therapy and Its Potential Impact on Cancer Treatment – City of Hope
Shen Li

The Science Behind TIL Therapy and Its Potential Impact on Cancer Treatment – City of Hope

City of Hope shared a post on LinkedIn:

“In a new City of Hope Research News article, Shen Li, M.D., surgical oncologist at City of Hope Chicago, explores how Tumor-infiltrating lymphocyte (TIL) therapy has evolved from an experimental concept to an FDA-approved treatment for some patients with advanced melanoma and where research could take this innovative approach next.

Read more about the science behind TIL therapy and its potential impact on the future of cancer treatment.”

Title: Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions

Authors: Shen Li, Alexandra E. Rojek, Reid Shaw, Cristina O’Donoghue, J. Michael Millis, Daniel J. Olson

Read the Full Article on Cancer

The Science Behind TIL Therapy and Its Potential Impact on Cancer Treatment - City of Hope

Other posts about City of Hope on OncoDaily.

 

Alexandra E. Rojek cancer City of Hope Cristina O’Donoghue Daniel J. Olson J. Michael Millis OncoDaily Oncology Reid Shaw Shen Li